ArticleDiscover oncology2025
Decoding epithelial-T cell interactions in colorectal cancer through single-cell and spatial transcriptomics.
Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Integrated single-cell and spatial transcriptomic analyses reveal malignant epithelial glycolytic heterogeneity and spatial niche remodeling during colorectal cancer progression.Functional & integrative genomics · 2026Article
- Applications and development of in situ nucleic acid visualization techniques.Frontiers in bioengineering and biotechnology · 2026Review
- Identification and experimental validation of prognostic genes associated with dietary restriction-related signatures in bladder cancer.Frontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundColorectal cancer (CRC) is a heterogeneous malignancy shaped by genetic alterations and immune microenvironmental interactions. While single-cell RNA sequencing (scRNA-seq) has uncovered diverse epithelial and T cell subsets, the spatial architecture of their crosstalk remains poorly understood.
methodsWe integrated scRNA-seq and spatial transcriptomics data from 36 CRC patients to comprehensively characterize epithelial and T cell heterogeneity, differentiation dynamics, and intercellular communication networks. Data preprocessing and integration were conducted using Seurat and Harmony. Cell trajectory inference was performed via CytoTRACE and Slingshot. Ligand-receptor signaling was assessed using CellChat, while spatial mapping was achieved using CellTrek.
resultsNine epithelial and eight T cell subpopulations were identified, each exhibiting distinct transcriptional states, CNV burdens, and pseudotime trajectories. CD8⁺ T_GZMK cells displayed tumor-specific activation signatures and engaged in enriched communication with epithelial subsets through CEACAM, APP, and MIF signaling pathways. Spatial transcriptomics confirmed the in situ colocalization of CD8⁺ T_GZMK cells with PTP4A3⁺ epithelial cells in tumor regions, revealing spatially organized epithelial-immune niches. These interactions suggest potential mechanisms of immune modulation and tumor progression.
conclusionThis study provides an integrative single-cell and spatial atlas of CRC, revealing structured epithelial-T cell communication and spatial architecture within the tumor microenvironment. Our findings offer novel insights into immune-epithelial crosstalk and identify signaling pathways that may serve as therapeutic targets or biomarkers for CRC precision treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.